Search
for
Sort by
Research 151–180 of 1000+
- Therapeutic Potential of Brassinosteroids in Biomedical and Clinical Research
- Case Report: Rowell Syndrome–Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Fissistigma oldhamii (Hemsl.) Merr.: Ethnomedicinal, Phytochemistry, and Pharmacological Aspects
- Skin Disorders in Athletes: Professional and Recreational Sports
- The spectrum of nephrocutaneous diseases and associations
- MALE PATTERN ALOPECIA
- Medications
- The Skin and Subcutaneous Tissues
- Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity
- Systemic causes of hair loss
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Th1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Drug-Induced Skin, Nail and Hair Disorders
- ANALYSIS OF ELEMENTAL COMPOSITION FROM NON-DIABETIC AND DIABETIC PATIENTS HAIRS, NAILS AND BLOOD USING SCANNING ELECTRON MICROSCOPY (SEM) AND ENERGY DISPERSIVE X-RAY SPECTROSCOPY (EDS)
- AROMA THERAPY: AN ART OF HEALING
- Unwanted hair.
- PLAU and SerpinB2 role in apoptosis in leprosy
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- Green hair discoloration due to selenium sulfide
- Case of alopecia induced by sorafenib, possible mechanism similar to alopecia areata
- Common pathologic pathways: A single prescription dream?
- Cross-sex hormone therapy for gender dysphoria
- The pathogenesis of alopecia areata
- Ancient-modern concordance in Ayurvedic plants: some examples.
- Dermatolojik Problemler ve COVID-19
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients